$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
How to handle capmatinib (Touradida) correctly after missing a dose
2026-02-01 22:25:32
Check Details
Is sotoracib (AMG 510) combined with PD-1 immunotherapy more effective?
2026-02-01 22:25:32
Check Details
Whether adagrasib (Krazati) can be vaccinated and what precautions should be taken during vaccination
2026-02-01 22:25:32
Check Details
Interpretation of the efficacy and price of the cancer targeted drug Lorlatinib: the medication and purchasing guide that patients are most concerned about
2026-02-01 22:25:32
Check Details
Related introduction of Dawnzera (donidalorsen): What kind of medicine is it used to treat?
2026-02-01 22:25:32
Check Details
Enzalutamide combined with leuprolide produces OS benefit in patients with non-Hodgkin lymphoma with biochemical recurrence
2026-02-01 22:25:32
Check Details
What are the main targets of Sorafenib/Nexavar and how do they work?
2026-02-01 22:25:32
Check Details
Is pemetinib/pemetinib included in the national medical insurance?
2026-02-01 22:25:32
Check Details
Full text analysis of Erdafitinib/Bocco drug instructions
2026-02-01 22:25:32
Check Details
Dacomitinib/Dozerun can be taken for a maximum of several years
2026-02-01 22:25:32
Check Details
Dawnzera (donidalorsen) instruction manual Chinese introduction
2026-02-01 22:25:32
Check Details
Analysis of the Differences, Advantages and Disadvantages of Brigatinib/Brigatinib and Cabozantinib
2026-02-01 22:25:32
Check Details
1
2
...
1994
1995
1996
1997
1998
1999
2000
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma